학술논문
The HOPE4MCI study: A randomized double‐blind assessment of AGB101 for the treatment of MCI due to AD.
Document Type
Article
Author
Source
Alzheimer's & Dementia: Translational Research & Clinical Interventions; Jan2024, Vol. 10 Issue 1, p1-11, 11p
Subject
Language
ISSN
23528737
Abstract
Copyright of Alzheimer's & Dementia: Translational Research & Clinical Interventions is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)